| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jaime M Monti, Seithikurippu R Pandi-Peruma. Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing Psychiatrists. Clinical neuropharmacology. 2022-02-28. PMID:35221321. |
clinical management of sleep and sleep disorders with cannabis and cannabinoids: implications to practicing psychiatrists. |
2022-02-28 |
2023-08-13 |
Not clear |
| Ali E Dabiri, Ghassan S Kassa. Effects of Cannabis on Cardiovascular System: The Good, the Bad, and the Many Unknowns. Medical cannabis and cannabinoids. vol 4. issue 2. 2022-02-28. PMID:35224427. |
the purpose of this review was to provide an overview of the known medicinal benefits of selected cannabis cannabinoids and the known side effects or contraindications. |
2022-02-28 |
2023-08-13 |
Not clear |
| Kaleb Bogale, Wesley Raup-Konsavage, Shannon Dalessio, Kent Vrana, Matthew D Coate. Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease. Medical cannabis and cannabinoids. vol 4. issue 2. 2022-02-28. PMID:35224429. |
similarly, a growing number of animal and human studies have been undertaken to evaluate the impact of cannabis and cannabinoid signaling elements on the natural history of ibd and its associated complications. |
2022-02-28 |
2023-08-13 |
human |
| Kaleb Bogale, Wesley Raup-Konsavage, Shannon Dalessio, Kent Vrana, Matthew D Coate. Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease. Medical cannabis and cannabinoids. vol 4. issue 2. 2022-02-28. PMID:35224429. |
in this review, we discuss the role of cannabis and cannabinoid signaling in visceral pain perception, what is currently known regarding the efficacy of cannabis and its derivatives for managing pain, related symptoms and inflammation in ibd, and what work remains to effectively utilize cannabis and its derivatives in the clinical setting. |
2022-02-28 |
2023-08-13 |
human |
| Holly Mansell, Declan Quinn, Lauren E Kelly, Jane Alcor. Cannabis for the Treatment of Attention Deficit Hyperactivity Disorder: A Report of 3 Cases. Medical cannabis and cannabinoids. vol 5. issue 1. 2022-02-28. PMID:35224434. |
blood samples were also collected from the patients to determine the plasma concentrations of the cannabinoids and relevant metabolites before and after a cannabis administration. |
2022-02-28 |
2023-08-13 |
Not clear |
| Holly Mansell, Declan Quinn, Lauren E Kelly, Jane Alcor. Cannabis for the Treatment of Attention Deficit Hyperactivity Disorder: A Report of 3 Cases. Medical cannabis and cannabinoids. vol 5. issue 1. 2022-02-28. PMID:35224434. |
cannabinoids, however, were not detected prior to dosing, suggesting that cannabis played a complimentary role in the therapeutic regimen of these 3 patients. |
2022-02-28 |
2023-08-13 |
Not clear |
| Donald I Abram. Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care. Integrative cancer therapies. vol 21. 2022-02-28. PMID:35225051. |
cannabis, cannabinoids and cannabis-based medicines in cancer care. |
2022-02-28 |
2023-08-13 |
Not clear |
| Donald I Abram. Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care. Integrative cancer therapies. vol 21. 2022-02-28. PMID:35225051. |
despite preclinical evidence and social media claims, the utility of cannabis, cannabinoids or cannabis-based medicines in the treatment of cancer remains to be convincingly demonstrated. |
2022-02-28 |
2023-08-13 |
Not clear |
| Shana M Augustin, David M Lovinge. Synaptic changes induced by cannabinoid drugs and cannabis use disorder. Neurobiology of disease. 2022-02-27. PMID:35219856. |
synaptic changes induced by cannabinoid drugs and cannabis use disorder. |
2022-02-27 |
2023-08-13 |
Not clear |
| Shana M Augustin, David M Lovinge. Synaptic changes induced by cannabinoid drugs and cannabis use disorder. Neurobiology of disease. 2022-02-27. PMID:35219856. |
despite the widespread use of cannabis and cannabinoids as therapeutic agents, little is known about the neurobiological mechanisms associated with cud and cannabinoid drug use. |
2022-02-27 |
2023-08-13 |
Not clear |
| Shana M Augustin, David M Lovinge. Synaptic changes induced by cannabinoid drugs and cannabis use disorder. Neurobiology of disease. 2022-02-27. PMID:35219856. |
in this article, we discuss the advances in research spanning animal models to humans on cannabis and synthetic cannabinoid actions on synaptic transmission, highlighting the neurobiological mechanisms following acute and chronic drug exposure. |
2022-02-27 |
2023-08-13 |
Not clear |
| Lin Li, Jin Feng, Lei Sun, Yao-Wei Xuan, Li Wen, Yun-Xia Li, Shuo Yang, Biao Zhu, Xiao-Yu Tian, Shuang Li, Li-Sheng Zhao, Rui-Jie Dang, Ting Jiao, Hai-Song Zhang, Ning We. Cannabidiol Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in the Inflammatory Microenvironment via the CB2-dependent p38 MAPK Signaling Pathway. International journal of stem cells. 2022-02-27. PMID:35220282. |
cannabidiol (cbd) is a natural cannabinoid with multiple biological activities, including anti-inflammatory and osteogenic potential. |
2022-02-27 |
2023-08-13 |
Not clear |
| Mona Khoury, Idan Cohen, Gil Bar-Sel. "The Two Sides of the Same Coin"-Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained. Pharmaceutics. vol 14. issue 2. 2022-02-26. PMID:35214123. |
"the two sides of the same coin"-medical cannabis, cannabinoids and immunity: pros and cons explained. |
2022-02-26 |
2023-08-13 |
Not clear |
| Mona Khoury, Idan Cohen, Gil Bar-Sel. "The Two Sides of the Same Coin"-Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained. Pharmaceutics. vol 14. issue 2. 2022-02-26. PMID:35214123. |
in this review, current knowledge and perceptions of cannabis or cannabinoids and their impact on various immune-system components will be discussed as the "two sides of the same coin" or "double-edged sword", referring to something that can have both favorable and unfavorable consequences. |
2022-02-26 |
2023-08-13 |
Not clear |
| Ana M Martins, Ana L Gomes, Inês Vilas Boas, Joana Marto, Helena M Ribeir. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals (Basel, Switzerland). vol 15. issue 2. 2022-02-26. PMID:35215320. |
the legalization of cannabis by a growing number of countries has opened the way for researching the use of cannabinoids in therapeutic topical formulations. |
2022-02-26 |
2023-08-13 |
Not clear |
| Catherine DeMarino, Maria Cowen, Pooja Khatkar, Bianca Cotto, Heather Branscome, Yuriy Kim, Sarah Al Sharif, Emmanuel T Agbottah, Weidong Zhou, Cecilia T Costiniuk, Mohammad-Ali Jenabian, Cohava Gelber, Lance A Liotta, Dianne Langford, Fatah Kashanch. Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription. Cells. vol 11. issue 4. 2022-02-25. PMID:35203372. |
cannabidiol (cbd) and Δ9-tetrahydrocannabinol (thc), the primary cannabinoids present in cannabis, are effective in reducing inflammation. |
2022-02-25 |
2023-08-13 |
human |
| Ricardo Lacava Bailone, Hirla Costa Silva Fukushima, Luis Kluwe de Aguiar, Ricardo Carneiro Borr. The endocannabinoid system in zebrafish and its potential to study the effects of Cannabis in humans. Laboratory animal research. vol 38. issue 1. 2022-02-23. PMID:35193700. |
the endocannabinoid system in zebrafish and its potential to study the effects of cannabis in humans. |
2022-02-23 |
2023-08-13 |
human |
| Michael Kenned. Cannabis, cannabidiol and tetrahydrocannabinol in sport: An overview. Internal medicine journal. 2022-02-22. PMID:35191178. |
the world antidoping agency now allows cannabidiol (cbd) to be taken in elite sport but has retained all other cannabinoids on its banned list. |
2022-02-22 |
2023-08-13 |
Not clear |
| Dmytro Isaev, Waheed Shabbir, Ege Y Dinc, Dietrich E Lorke, Georg Petroianu, Murat O. Cannabidiol Inhibits Multiple Ion Channels in Rabbit Ventricular Cardiomyocytes. Frontiers in pharmacology. vol 13. 2022-02-21. PMID:35185573. |
cannabidiol (cbd), a major non-psychotropic cannabinoid found in the cannabis plant, has been shown to exert anti-nociceptive, anti-psychotic, and anti-convulsant effects and to also influence the cardiovascular system. |
2022-02-21 |
2023-08-13 |
rabbit |
| Hina Khan, Fareeha Khalid Ghori, Uzma Ghani, Aneela Javed, Saadia Zahi. Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis. Molecular biology reports. 2022-02-19. PMID:35182322. |
clinical studies have suggested the therapeutic potential of cannabinoids derived from cannabis sativa in relieving pain, tremors and spasticity. |
2022-02-19 |
2023-08-13 |
Not clear |